Antibodies taken from alpacas are to be used in a new pandemic flu drug, in a £33 million project led by AstraZenica.

Antibodies taken from alpacas are to be used in a new pandemic flu drug, in a £33 million project led by AstraZeneca. If successful, the trial could “usher in a new era” of affordable ...

Influenza is an acute respiratory disease that causes epidemics and pandemics in the human population of temperate regions. Influenza epidemics occur every year during the winter months, affecting ...

Seasonal flu cases have hit a 15-year high this year—filling hospitals, shutting down schools, and leading to an estimated 19,000 flu-related deaths so far in the United States. These deaths ...

The USDA plans to invest up to $100 million in research for bird flu therapies and vaccines. The U.S. will also import more ...

The market for these drugs includes antiviral medications such as neuraminidase inhibitors, polymerase acidic protein inhibitors, and combination therapies. The increasing incidence of seasonal flu ...

Influenza virus infection is well known to predispose an individual to asthma exacerbation and bacterial infections. These complications can occur concurrently with influenza or in a delayed ...

Antibody-based immune therapy could become a key weapon in the fight against bird flu after trials in monkeys successfully prevented severe illness and death from the infection. The preventative ...

(HealthDay News) — A federal vaccine advisory panel work session focused on next year’s flu shot has been canceled without explanation. It is the second vaccine advisory meeting that has been ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...

Additionally, collaborations between pharmaceutical companies and research institutions play a crucial role in accelerating drug development and bringing new therapies to market. The Influenza A Virus ...